Hillsborough, CA, United States of America

Daniel J Capon

This inventor holds 33 USPTO granted patents and 12 published patent applications, plus 9 CIPO patents and 9 EPO patents, primarily in Chimeric Antibodies. Top assignees: Biomolecular Holdings LLC, Cell Genesys, Inc., Abgenix, Inc.. Active years: 1994-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel J Capon. Retrieved from https://idiyas.com/inventor/daniel-j-capon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 33 

% Patents Active = 90.9


 

Average Co-Inventor Count = 2.0

ph-index = 19

Forward Citations = 4,518(Granted Patents)


Company Filing History:


Years Active: 1994-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Tetrahedral Antibodies
Hybrid Immunoglobulin
NK/Monocyte Engagers
Peptide-Hinge-Free
Affinity Support
Xenogeneic Antibodies
Chimeric Receptors
Human Antibodies
Universal Donor Cells
Signal Transduction
Anti-Viral Drug Screening
Receptor-Associated
33 patents (USPTO):Explore Patents

Title: The Innovative Mind of Daniel J Capon

Introduction

Daniel J Capon is a notable inventor based in Hillsborough, California, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 27 patents, his work has made a remarkable impact on the development of antibody-like molecules and hybrid immunoglobulins.

Latest Patents

Capon's latest patents include groundbreaking inventions that enhance binding affinity and create novel structures in antibody technology. One of his notable inventions is the "Peptide-hinge-free flexible antibody-like molecule." This invention offers an innovative antibody capable of binding to targets with greater affinity, featuring a flexible molecule with a nonpeptide hinge part. The detailed structure involves a general formula that includes amino acids and alkyleneoxide groups, culminating in an advanced antibody Fc fragment.

Another significant patent is the "Hybrid immunoglobulin containing non-peptidyl linkage." This invention presents a compound structure that consists of two polypeptide components, which are integral in developing antibodies that interact with Freceptors. The linkage configurations enhance the compound's ability to bridge amino acid sequences while incorporating both peptidyl and non-peptidyl connections.

Career Highlights

Throughout his career, Daniel Capon has worked with leading biotechnology companies such as Cell Genesys, Inc. and Abgenix, Inc., where he focused on advancing therapeutic antibody technology. His expertise in developing novel antibody structures is recognized in the scientific community and has led to numerous patents that address critical needs in drug development.

Collaborations

Capon has collaborated with distinguished professionals in the field, including Raju S Kucherlapati and Aya Jakobovits. These partnerships have fostered innovative research and development, further enhancing the progression of therapeutic solutions in biotechnology.

Conclusion

Daniel J Capon stands out as a pioneering inventor with a wealth of experience in developing advanced biotechnological solutions. His contributions, particularly in the realm of antibody-like molecules and their applications, continue to drive innovation and inspire future research in the field. With his extensive patent portfolio, Capon remains a key figure in the ongoing advancement of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…